News
Other common symptoms include swelling in parts of the body ... on treatment were eligible to participate in the open-label extension of the trials. FILSPARI (sparsentan) is indicated to slow kidney ...
Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...
The FDA has set a goal date of Aug. 27, 2025. If approved, the therapy would be branded as Lytenava and be the first ...
10d
MedPage Today on MSNEnthusiasm Dries Up for Fluid Restriction in Heart FailureCHICAGO -- For people with heart failure (HF), the long-presumed benefits of fluid restriction did not pan out in the ...
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD ... Vafseo, which is part of the hypoxia-inducible factor–prolyl hydroxylase inhibitor (HIF-PHI) branch ...
US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...
Netflix’s Adolescence drama explores teen radicalisation through a gripping crime narrative where emojis reveal hidden ...
Canned food is easy, convenient and quick, but it's not always healthy. Canned food has a longer shelf life because part of ...
Since Donald Trump’s return to the White House, US companies have all but abandoned the green bonds that were once touted as a way for corporate America to have a hand in fixing the planet.
12d
GlobalData on MSNMSD’s subcutaneous Keytruda non-inferior to IV version of blockbuster drugCompared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results